# The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis–to-need ratio in the fourth quarter of 2017, United States

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-prevalence-of-pre-exposure-prophylaxis-use-and-the-pre-exposure-prophylaxis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Aaron J. Siegler,Farah Mouhanna,Robertino M. Mera,Kevin M. Weiss,Elizabeth Pembleton,Jodie L. Guest,Jeb Jones,Amanda D. Castel,Howa Yeung,Michael R. Kramer,Scott McCallister,Patrick S. Sullivan |
| Citations | 431 |
| DOI | 10.1016/j.annepidem.2018.06.005 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.sciencedirect.com/science/article/pii/S1047279718301078/pdf |
| OpenAlex ID | https://openalex.org/W2808046551 |
| PMID | 29983236 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Michael R. Kramer](https://scholariq.org/researchers/michael-r-kramer/)

## Paper journal

- [Annals of Epidemiology](https://scholariq.org/journals/annals-of-epidemiology/)

## Paper primary topic

- [HIV/AIDS Research and Interventions](https://scholariq.org/topics/hiv-aids-research-and-interventions/)

## Paper topics

- [HIV/AIDS Research and Interventions](https://scholariq.org/topics/hiv-aids-research-and-interventions/)
- [HIV, Drug Use, Sexual Risk](https://scholariq.org/topics/hiv-drug-use-sexual-risk/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.